March 03, 2015 10:10 AM ET

Health Care Technology

Company Overview of NextBio, Inc.

Company Overview

NextBio, Inc. provides a scientific platform for biologists and clinicians to aggregate and interpret genomic data for research and clinical applications. The company offers NextBio Clinical that enables the users to apply data analysis and interpretation in various ways to biomarker discovery, translational research, and clinical trials, as well as allows the correlation of patients’ molecular and clinical data from public and proprietary studies in an integrated context; and NextBio Research that provides tools and content for exploratory, preclinical, and early translational research in drug discovery and biotechnology research, as well as supports early-stage and translational discovery ...

451 El Camino Real

Suite 210

Santa Clara, CA 95050

United States

Founded in 2003





Key Executives for NextBio, Inc.

Co-Founder, Chief Executive Officer and President
Co-Founder and Vice President of Products
Chief Financial Officer and Vice President of Corporate Development
Chief Technology Officer and Vice President of Engineering
Head of Clinical Development
Compensation as of Fiscal Year 2014.

NextBio, Inc. Key Developments

Boehringer Ingelheim Renews and Expands License to NextBio Research Platform

NextBio announced that Boehringer Ingelheim has signed a multi-year renewal agreement to the NextBio Research Platform. The new agreement also expands the user base for NextBio across Boehringer Ingelheim's global research organization.

NextBio, Inc. Announces Translational Medicine Partnership with Sanofi

NextBio, Inc. announced a multi-year collaboration with Sanofi aimed at using NextBio Clinical to incorporate patient omics and clinical data into Sanofi's drug research and development, as part of Sanofi's Translational Medicine for Patients (TM4P) program. NextBio will provide Sanofi with the NextBio Clinical platform for aggregation, standardization and analysis of patient clinical data, next generation sequencing (NGS) and other molecular data across public data sources, Sanofi clinical trials and Sanofi hospital partners. NextBio's unique data integration platform, user interface and real-time Big Data analytics will allow Sanofi biologists and clinicians to tap into a vast, growing collection of patient data as it becomes available, as a key enabling technology for translational and clinical research.

NextBio, Inc. and Genophen, Inc. Form Partnership Aimed at Applying Genomics to Personalized Disease Prevention and Wellness

NextBio, Inc. and Genophen, Inc. announced a partnership aimed at furthering the adoption of genomics for disease prevention and wellness. The partnership enables Genophen to interpret full genome sequencing data from individuals through the use of the NextBio Clinical platform and to combine this data with a person's environmental, behavioral and clinical factors to create a uniquely tailored disease prevention and wellness plan for its individual members.

Similar Private Companies By Industry

Company Name Region
MMJMenu, LLC United States
Global Record Systems, LLC United States
LYNX Medical Systems, Inc. United States
Mobile Health Engagement Strategies,LLC United States
Three Palm Software LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
No data available

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NextBio, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at